Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial Meeting Abstract
| Authors: | Sharman, J.; Coutre, S.; Furman, R.; Cheson, B.; Pagel, J.; Hillmen, P.; Barrientos, J.; Zelenetz, A.; Kipps, T.; Flinn, I.; Ghia, P.; Hallek, M.; Coiffier, B.; O'Brien, S.; Stilgenbauer, S. |
| Abstract Title: | Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial |
| Meeting Title: | 5th International Eurasian Hematology Congress |
| Journal Title: | Leukemia Research |
| Volume: | 38 |
| Issue: | Suppl.1 |
| Meeting Dates: | 2014 Oct 15-19 |
| Meeting Location: | Antalya, Turkey |
| ISSN: | 0145-2126 |
| Publisher: | Elsevier Ltd |
| Date Published: | 2014-10-01 |
| Start Page: | S44 |
| End Page: | S45 |
| Language: | English |
| ACCESSION: | WOS:000347244200102 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0145-2126(14)70108-0 |
| Notes: | Meeting Abstract: PP-054 -- 5th International Eurasian Hematology Congress -- OCT 15-19, 2014 -- Antalya, TURKEY -- 1 -- Source: Wos |
